Cite
HARVARD Citation
Yamazaki, H. et al. (n.d.). P827: EFFICACY AND SAFETY OF ROMIPLOSTIM ADDED TO IMMUNOSUPPRESSIVE THERAPY AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. HemaSphere. pp. 721-722. [Online].